Skip to main content

02-10-2019 | Non-small cell lung cancer | Video | Article

Expert highlights: Lung and thoracic cancers at ESMO 2019

Ross Camidge comments on the advanced non-small-cell lung cancer research that caught his attention at the ESMO Congress 2019, including the FLAURA and CheckMate 227 overall survival data, and updates on brigatinib and lorlatinib (3:01).

Receive weekly updates on the oncology news that matters

Read the transcript

Back to the WCLC 2019 conference hub

Related topics